Announcement

Collapse
No announcement yet.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi . Clinical analysis of 126 patients with coronavirus disease 2019 with pharyngeal symptoms

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi . Clinical analysis of 126 patients with coronavirus disease 2019 with pharyngeal symptoms


    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi


    . 2020 Nov 7;55(11):1032-1036.
    doi: 10.3760/cma.j.cn115330-20200411-00288.
    [Clinical analysis of 126 patients with coronavirus disease 2019 with pharyngeal symptoms]


    [Article in Chinese]

    W Zhang 1 , Y Xu 2 , R Xiang 1 , L Gao 1



    Affiliations

    Abstract

    in English, Chinese
    Objective: To investigate the clinical characteristics of patients with coronavirus disease 2019 (COVID-19) with pharyngeal symptoms. Methods: From January 10 to May 15, 2020, clinical data of 1 228 patients with COVID-19 in Renmin Hospital of Wuhan University was collected (554 males and 674 females, with the range of age from 10 to 95 years old, the average age was 55.2 years old). The patients were divided into pharyngeal symptoms group (PS, 126 cases) and non-pharyngeal symptoms group (Non-PS, 1 102 cases) according to the presence or absence of pharyngeal symptoms such as pharyngalgia, pharyngeal dryness, pharyngeal itching, and pharyngeal foreign body sensation. The clinical data in terms of age, sex, medical history, duration of symptoms, treatment time, clinical classification, pulmonary imaging findings, whole blood cell count, serum hypersensitivity C-reactive protein, C-reactive protein, procalcitonin were statistically analyzed between the two groups. Chi-square, Fisher's exact test and Mann-Whitney U test were used for statistical analysis. Results: The most common pharyngeal symptoms were pharyngalgia (59.52%, 75/126), followed by foreign body sensation (23.02%, 29/126), pharyngeal dryness (8.73%, 11/126), and itching (8.73%, 11/126). The median age of the patients in the PS group was 51.50 years old, which was less than 57.50 years old in the non-PS group, showing a significant difference (P<0.05). The female cases accounted for 65.08% (82/126), which was higher than 53.72% (592/1 102) of the non-PS group (P<0.05). The incidence of bilateral lung inflammation confirmed by CT images was 73.81% (93/126), which was significantly lower than 83.48% (920/1 102) in the non-PS group (P<0.05). No significant differences were shown in the proportion of patients with clinical types, treatment days, duration of symptoms, white blood cell count, lymphocyte count, lymphocyte percentage, eosinophil count, eosinophil percentage, hypersensitive C-reactive protein, C-reactive protein, D-dimer, procalcitonin and other indicators (P>0.05). Conclusions: The incidence of pharyngeal symptoms in patients with COVID-19 is 10.26%. Most of these symptoms occur before or at the same time as the common symptoms of the disease. Therefore, patients with such symptoms may bring a greater risk of infection to otolaryngologist. According to the current clinical classification criteria, pharyngeal symptoms have no obvious correlation with the degree of the disease; but the presence of pharyngeal symptoms may suggest a milder clinical presentation and a better prognosis.

    Keywords: Angiotensin converting enzyme 2; Coronavirus disease 2019; Pharyngeal symptom; S

Working...
X